Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Health Study II (LHSII)
NCT00000569Phase 3Completed
- Sponsor
- University of Minnesota
- Start
- Sep 1993
- Primary completion
- May 1999
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of triamcinolone in chronic obstructive pulmonary disease (COPD), sponsored by University of Minnesota. Started Sep 1993; status: completed.
02
Drugs
triamcinolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00000569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000569.